Published in Eur J Clin Microbiol on December 01, 1986
Epidemiologic typing and delineation of genetic relatedness of methicillin-resistant Staphylococcus aureus by macrorestriction analysis of genomic DNA by using pulsed-field gel electrophoresis. J Clin Microbiol (1992) 6.50
Rapid field inversion gel electrophoresis in combination with an rRNA gene probe in the epidemiological evaluation of staphylococci. J Clin Microbiol (1990) 4.08
Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible S. aureus isolates. J Clin Microbiol (1992) 1.86
Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A (1998) 21.41
Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology (1995) 8.08
Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother (1997) 3.78
Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS (1997) 3.32
Multiplex PCR for the detection of tetracycline resistant genes. Mol Cell Probes (2001) 3.03
The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ (2001) 2.99
Physical states of staphylococcal alpha-toxin. J Bacteriol (1967) 2.66
Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology (1999) 2.26
Toxic epidermal necrolysis produced by an extracellular product of Staphylococcus aureus. Br J Dermatol (1971) 2.23
Interaction of staphylococcal alpha-toxin with artificial and natural membranes. J Bacteriol (1968) 2.11
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol (1999) 2.10
Toxins of Staphylococcus aureus. Pharmacol Ther (1982) 2.08
Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother (1998) 2.03
Analysis of the reduction in expression of tetracycline resistance determined by transposon Tn10 in the multicopy state. Mol Gen Genet (1981) 1.97
Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol (1999) 1.96
Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation. J Gen Microbiol (1992) 1.94
Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: molecular mechanism of triple conversion. J Gen Microbiol (1989) 1.83
Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J Med Microbiol (1996) 1.81
Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J Virol (2000) 1.78
Candida dubliniensis: phylogeny and putative virulence factors. Microbiology (1998) 1.76
Partial characterisation of Escherichia coli haemolysin. J Med Microbiol (1974) 1.74
Comparison of molecular methods for typing Vibrio parahaemolyticus. J Clin Microbiol (1999) 1.70
Enterobacter cloacae in a haematology/oncology ward--first impressions. J Hosp Infect (1989) 1.61
Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits. Infect Immun (1984) 1.60
Emerging pathogens. Med Mycol (2000) 1.59
Cloning, and expression in Escherichia coli K-12, of the chromosomal hemolysin (phospholipase C) determinant of Pseudomonas aeruginosa. J Bacteriol (1983) 1.58
Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J Clin Microbiol (1998) 1.57
Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-D-glucoside as determined with the API 20C AUX and vitek YBC systems. J Clin Microbiol (1999) 1.54
Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53
Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol (2000) 1.49
Qualitative and quantitative methods for detecting staphylococcal epidermolytic toxin. J Med Microbiol (1976) 1.49
The kinetics of erythrocyte lysis by Escherichia coli haemolysin. J Med Microbiol (1974) 1.48
Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. J Clin Microbiol (2008) 1.47
Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting. J Clin Microbiol (1995) 1.46
Genomic DNA fingerprinting of clinical isolates of Helicobacter pylori using short oligonucleotide probes containing repetitive sequences. J Appl Bacteriol (1996) 1.45
Lipid-induced polymerization of staphylococcal -toxin. J Gen Microbiol (1973) 1.44
Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model. Infect Immun (1985) 1.43
A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals. J Virol (2001) 1.37
Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project. Can J Infect Dis (1997) 1.34
Staphylococcal toxins in human disease. Soc Appl Bacteriol Symp Ser (1990) 1.33
Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol (1999) 1.31
Candida dubliniensis: An update. Rev Iberoam Micol (1999) 1.31
Epidemiological typing of MRSA isolates from blood cultures taken in Irish hospitals participating in the European Antimicrobial Resistance Surveillance System (1999-2003). Eur J Clin Microbiol Infect Dis (2006) 1.30
Plasmids in epidermolytic strains of Staphylococcus aureus. J Gen Microbiol (1981) 1.30
Novel organization of the site-specific integration and excision recombination functions of the Staphylococcus aureus serotype F virulence-converting phages phi 13 and phi 42. Mol Microbiol (1995) 1.29
A comparative study of two serotypes of epidermolytic toxin from Staphylococcus aureus. Biochim Biophys Acta (1980) 1.28
Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Can J Infect Dis (1999) 1.28
Multiple forms of staphylococcal alpha-toxin. J Med Microbiol (1972) 1.28
Effect immunization with highly purified alpha- and beta-toxins on staphylococcal mastitis in rabbits. Infect Immun (1977) 1.27
Effects of staphylococcal products on locomotion and chemotaxis of human blood neutrophils and monocytes. J Med Microbiol (1976) 1.27
Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol (2001) 1.26
A simple method for the study in vivo of bacterial growth and accompanying host response. J Infect (1980) 1.23
Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet Biol (2007) 1.22
Effects of staphylococcal -toxin on the structure of erythrocyte membranes: a biochemical and freeze-etching study. J Gen Microbiol (1973) 1.20
A toxic shock syndrome toxin mutant of Staphylococcus aureus isolated by allelic replacement lacks virulence in a rabbit uterine model. FEMS Microbiol Lett (1991) 1.19
Experimental staphylococcal infections in newborn mice: inhibition of weight gain as an index of virulence. J Med Microbiol (1980) 1.19
Cloning and expression of the Haemophilus influenzae transferrin receptor genes. Mol Microbiol (1996) 1.18
Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease. Infect Immun (1997) 1.17
Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers. J Med Microbiol (1989) 1.13
A histopathological study of the effects of highly purified staphlococcal alpha and beta toxins on the lactating mammary gland and skin of the rabbit. J Comp Pathol (1979) 1.13
Consequences of spingomyelin degradation in erythrocyte ghost membranes by staphylococcal beta-toxin (sphingomyelinase C). Toxicon (1974) 1.12
Nonadditive effects of leaf litter species diversity on breakdown dynamics in a detritus-based stream. Ecology (2007) 1.12
Isoelectric focusing studies of staphylococcal epidermolytic toxin. FEBS Lett (1974) 1.12
Toxic shock syndrome in Britain. Br Med J (Clin Res Ed) (1982) 1.12
Staphylococci associated with toxic shock syndrome in the United Kingdom. Ann Intern Med (1982) 1.11
MDR1-mediated drug resistance in Candida dubliniensis. Antimicrob Agents Chemother (2001) 1.10
Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. J Clin Microbiol (2001) 1.10
Interaction of Clostridium perfringens theta-haemolysin, a contaminant of commercial phospholipase C, with erythrocyte ghost membranes and lipid dispersions. A morphological study. Biochim Biophys Acta (1975) 1.10
Molecular cloning and characterization of the genetic determinant encoding CS3 fimbriae of enterotoxigenic Escherichia coli. Microb Pathog (1987) 1.09
Properties of Escherichia coli grown in vivo using a chamber implant system. J Gen Microbiol (1982) 1.09
Isolation of C. dubliniensis from insulin-using diabetes mellitus patients. J Oral Pathol Med (2000) 1.09
Effect of toxic shock syndrome toxin 1 on chicken embryos. Infect Immun (1985) 1.08
Susceptibility to antimicrobial agents and analysis of plasmids in gentamicin- and methicillin-resistant Staphylococcus aureus from Dublin hospitals. J Med Microbiol (1985) 1.08
The Haemophilus influenzae HtrA protein is a protective antigen. Infect Immun (1998) 1.08
Azole susceptibility and resistance in Candida dubliniensis. Biochem Soc Trans (2005) 1.07
Lack of a relationship between Lewis antigen expression and cagA, CagA, vacA and VacA status of Irish Helicobacter pylori isolates. FEMS Immunol Med Microbiol (1999) 1.07
Properties of Clostridium perfringens (welchii) type-A alpha-toxin (phospholipase C) purified by electrofocusing. J Med Microbiol (1974) 1.06
Isogenic strain construction and gene targeting in Candida dubliniensis. J Bacteriol (2001) 1.06
Genetic variation among laboratory strains of the planorbid snail Biomphalaria glabrata. Biochem Genet (1981) 1.06
Characterization of staphylococcal gamma-lysin. J Gen Microbiol (1992) 1.05
Role of glycoprotein PE2 in formation and maturation of the Sindbis virus spike. J Virol (1997) 1.04
An epidemiological study of Candida species infection in cancer patients using genetic fingerprinting and morphotyping. J Hosp Infect (1995) 1.04
Prevalence of epidermolytic toxin in clinical isolates of Staphylococcus aureus. J Med Microbiol (1981) 1.02
Importation of methicillin-resistant Staphylococcus aureus from Baghdad to Dublin and subsequent nosocomial spread. J Hosp Infect (1990) 1.02
Characterisation of MRSA from Malta and the description of a Maltese epidemic MRSA strain. Eur J Clin Microbiol Infect Dis (2009) 1.02
Nitrogen Mineralization by Acanthamoeba polyphaga in Grazed Pseudomonas paucimobilis Populations. Appl Environ Microbiol (1981) 1.00
Molecular analysis of Helicobacter pylori populations in antral biopsies from individual patients using randomly amplified polymorphic DNA (RAPD) fingerprinting. FEMS Immunol Med Microbiol (1995) 0.99
A new methicillin- and gentamicin-resistant Staphylococcus aureus in Dublin: molecular genetic analysis. J Med Microbiol (1989) 0.99
Phylogenetic relationships within the aquatic snail genus Tryonia: implications for biogeography of the North American Southwest. Mol Phylogenet Evol (1999) 0.99
Role of exotoxins in bacterial pathogenicity. J Appl Bacteriol (1978) 0.98
Assays for epidermolytic toxin of Staphylococcus aureus. Methods Enzymol (1988) 0.98
Colonial dissociation and susceptibility to phagocytosis of Pseudomonas aeruginosa grown in a chamber implant model in mice. Infect Immun (1987) 0.98
Molecular cloning and genetic analysis of the determinant for gamma-lysin, a two-component toxin of Staphylococcus aureus. J Gen Microbiol (1988) 0.97
Cell-associated alpha-toxin from Staphylococcus aureus. J Med Microbiol (1972) 0.97
Cell envelope proteins of Staphylococcus epidermidis grown in vivo in a peritoneal chamber implant. Infect Immun (1992) 0.97
Foodborne illness: an overview. Lancet (1990) 0.97